Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Irritable Bowel Syndrome, January 2023 Free Subscription Abstracts Retrieve all available abstracts of the following 129 articles: HTML format

Single Articles

1. EBRAHIMLOEE S, Masoumpoor A, Nasiri M, Babaie M, et al
   The effect of Benson relaxation technique on the severity of symptoms and quality of life in children with irritable bowel syndrome (IBS): a quasi-experimental study.
   BMC Gastroenterol. 2022;22:547.
   PubMed    
   Abstract available
   
   

2. QI LY, Yang JW, Yan SY, Tu JF, et al
   Acupuncture for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Randomized Clinical Trial.
   JAMA Netw Open. 2022;5:e2248817.
   PubMed    
   Abstract available
   
   

3. MOTAWEA KR, Varney J, Gamal M, Abbas KS, et al
   Meta-analysis of the relation between irritable bowel syndrome and antibodies against endogenous gonadotropin-releasing hormone and its receptor.
   Proc (Bayl Univ Med Cent). 2022;36:61-65.
   PubMed    
   Abstract available
   
   

4. KAPLAN AI, Mazor Y, Prott GM, Sequeira C, et al
   Experiencing multiple concurrent functional gastrointestinal disorders is associated with greater symptom severity and worse quality of life in chronic constipation and defecation disorders.
   Neurogastroenterol Motil. 2022 Dec 28:e14524. doi: 10.1111/nmo.14524.
   PubMed    
   Abstract available
   
   

5. SU Q, Tun HM, Liu Q, Yeoh YK, et al
   Gut microbiome signatures reflect different subtypes of irritable bowel syndrome.
   Gut Microbes. 2023;15:2157697.
   PubMed    
   Abstract available
   
   

6. ROBERTS C, Albusoda A, Farmer AD, Aziz Q, et al
   Factors influencing rectal hypersensitivity in irritable bowel syndrome: A systematic review and meta-analysis.
   Neurogastroenterol Motil. 2022 Dec 26:e14515. doi: 10.1111/nmo.14515.
   PubMed    
   Abstract available
   
   

7. HARRABI F, Zaibi A, Bouazizi N, Bougmiza I, et al
   Prevalence and associated factors of lower digestive symptoms in type 2 diabetics in Tunisia.
   Tunis Med. 2022;100.
   PubMed    
   Abstract available
   
   

8. BEDNARSKA O, Biskou O, Israelsen H, Winberg ME, et al
   A postbiotic fermented oat gruel may have a beneficial effect on the colonic mucosal barrier in patients with irritable bowel syndrome.
   Front Nutr. 2022;9:1004084.
   PubMed    
   Abstract available
   
   

9. ANDERLE K, Wolzt M, Moser G, Keip B, et al
   Safety and efficacy of purified clinoptilolite-tuff treatment in patients with irritable bowel syndrome with diarrhea: Randomized controlled trial.
   World J Gastroenterol. 2022;28:6573-6588.
   PubMed    
   Abstract available
   
   

10. HAMAMAH S, Gheorghita R, Lobiuc A, Sirbu IO, et al
    Fecal microbiota transplantation in non-communicable diseases: Recent advances and protocols.
    Front Med (Lausanne). 2022;9:1060581.
    PubMed    
    Abstract available
    
    

11. XIE Z, Feng J, Hibberd TJ, Chen BN, et al
    Piezo2 channels expressed by colon-innervating TRPV1-lineage neurons mediate visceral mechanical hypersensitivity.
    Neuron. 2022 Dec 16:S0896-6273(22)01069-8. doi: 10.1016/j.neuron.2022.
    PubMed    
    Abstract available
    
    

12. CHEN M, Wu S, Chen T, Wang C, et al
    Information-Based Similarity of Ordinal Pattern Sequences as a Novel Descriptor in Obstructive Sleep Apnea Screening Based on Wearable Photoplethysmography Bracelets.
    Biosensors (Basel). 2022;12:1089.
    PubMed    
    Abstract available
    
    

13. 
    Use of an app to change dietary behaviour for IBS.
    Drug Ther Bull. 2023;61:5.
    PubMed    
    Abstract available
    
    

14. LI Y, Duan Z
    Updates in interaction of gastroesophageal reflux disease and extragastroesophageal digestive diseases.
    Expert Rev Gastroenterol Hepatol. 2022;16.
    PubMed    
    Abstract available
    
    

15. LI J, Liu H, Guo F, Guo R, et al
    Increased GABAergic projections in the paraventricular nucleus regulate colonic hypersensitivity via oxytocin in a rat model of irritable bowel syndrome.
    Neuroreport. 2023;34:108-115.
    PubMed    
    Abstract available
    
    

16. TOMITA T, Fukui H, Morishita D, Maeda A, et al
    Diarrhea-predominant Irritable Bowel Syndrome-like Symptoms in Patients With Quiescent Crohn's Disease: Comprehensive Analysis of Clinical Features and Intestinal Environment Including the Gut Microbiome, Organic Acids, and Intestinal Permeability.
    J Neurogastroenterol Motil. 2023;29:102-112.
    PubMed    
    Abstract available
    
    

17. CICIORA SL, Manickam K, Saps M
    Disorders of Gut-Brain Interaction in a National Cohort of Children With Down Syndrome.
    J Neurogastroenterol Motil. 2023;29:94-101.
    PubMed    
    Abstract available
    
    

18. LI R, Chen F, He X, Feng Y, et al
    Nocebo response intensity and influencing factors in the randomized clinical trials of irritable bowel syndrome: A systematic review and meta-analysis.
    Front Med (Lausanne). 2022;9:1018713.
    PubMed    
    Abstract available
    
    

19. GUO YX, Zhang SH, Wang AQ, Zhu XX, et al
    [Pharmacodynamic substances and therapeutic potential of Wuji Pills:based on UPLC-Q-TOF-MS/MS and network pharmacology].
    Zhongguo Zhong Yao Za Zhi. 2022;47:6720-6729.
    PubMed    
    Abstract available
    
    

20. ZHANG RQ, Fang ZA, Han WQ, Jing JQ, et al
    [Effect of Gegen Qinlian Decoction on gut microbiota of irritable bowel syndrome with diarrhea rats].
    Zhongguo Zhong Yao Za Zhi. 2022;47:6709-6719.
    PubMed    
    Abstract available
    
    

21. STURKENBOOM R, Essers BAB, Masclee AAM, Keszthelyi D, et al
    Do Patients' and Physicians' Perspectives Differ on Preferences for Irritable Bowel Syndrome Treatment?
    J Patient Exp. 2022;9:23743735221147762.
    PubMed    
    Abstract available
    
    

22. ACHARJEE A, Choudhury SP
    Artificial intelligence-based personalized nutrition and prediction of irritable bowel syndrome patients.
    Therap Adv Gastroenterol. 2022;15:17562848221145612.
    PubMed    
    
    
    

23. KIM JE, Song HJ, Choi YJ, Jin YJ, et al
    Improvement of the intestinal epithelial barrier during laxative effects of phlorotannin in loperamide-induced constipation of SD rats.
    Lab Anim Res. 2023;39:1.
    PubMed    
    Abstract available
    
    

24. WANG J, Zhao D, Lei Z, Ge P, et al
    TRIM27 maintains gut homeostasis by promoting intestinal stem cell self-renewal.
    Cell Mol Immunol. 2023 Jan 4. doi: 10.1038/s41423-022-00963.
    PubMed    
    Abstract available
    
    

25. WU S, Yang Z, Liu S, Zhang Q, et al
    Frailty status and risk of irritable bowel syndrome in middle-aged and older adults: A large-scale prospective cohort study.
    EClinicalMedicine. 2022;56:101807.
    PubMed    
    Abstract available
    
    

26. WAL A, Srivastava A, Verma N, Shanker Pandey S, et al
    The Role of Neutraceuticals Supplements in the Treatment of Irritable Bowel Syndrome: A Mini Review.
    Curr Pediatr Rev. 2023 Jan 2. doi: 10.2174/1573396319666230102121953.
    PubMed    
    Abstract available
    
    

27. MASOOD R, Mandalia K, Moverman MA, Puzzitiello RN, et al
    Patients with Functional Somatic Syndromes--Fibromyalgia, Irritable Bowel Syndrome, Chronic Headaches, and Chronic Low Back Pain--Have Lower Outcomes And Higher Opioid Usage And Cost After Shoulder And Elbow Surgery.
    Arthroscopy. 2022 Dec 30:S0749-8063(22)00867.
    PubMed    
    Abstract available
    
    

28. ERKILIC B, Dalgic GS
    The preventive role of vitamin D in the prevention and management of Fibromyalgia syndrome.
    Nutr Health. 2023 Jan 2:2601060221144801. doi: 10.1177/02601060221144801.
    PubMed    
    Abstract available
    
    

29. OZTURK A, Agbektas T, Tas A, Gul MA, et al
    The relationship between serum prolidase activity and histone H3 protein levels and fibromyalgia.
    Eur Rev Med Pharmacol Sci. 2022;26:9098-9106.
    PubMed    
    Abstract available
    
    

30. VOLKOVA YV, Mykhnevych KG, Ponomaryov VI, Dmytriiev DV, et al
    5-HT3 SEROTONIN RECEPTOR BLOCKERS FOR INTENSIVE THERAPY OF TRAUMATIC DISEASE IN PATIENTS WITH MULTIPLE TRAUMA.
    Wiad Lek. 2022;75.
    PubMed    
    Abstract available
    
    

31. ALTURKISTANI S
    Correlation between chronic conditions and job absenteeism among healthcare administration employees at King Abdullah Medical City in Makkah, Saudi Arabia.
    Work. 2022 Dec 26. doi: 10.3233/WOR-220157.
    PubMed    
    Abstract available
    
    

32. KE W, Wang Y, Huang S, Liu S, et al
    Paeoniflorin alleviates inflammatory response in IBS-D mouse model via downregulation of the NLRP3 inflammasome pathway with involvement of miR-29a.
    Heliyon. 2022;8:e12312.
    PubMed    
    Abstract available
    
    

33. YANG Y, Rao K, Zhan K, Shen M, et al
    Clinical evidence of acupuncture and moxibustion for irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Front Public Health. 2022;10:1022145.
    PubMed    
    Abstract available
    
    

34. ALHUZAIM WM, Alojayri AM, Albednah FA, Alshehri FF, et al
    Impact of Work Hours on the Quality of Life of Adult Employees With Irritable Bowel Syndrome in Saudi Arabia.
    Cureus. 2022;14:e31983.
    PubMed    
    Abstract available
    
    

35. SAWADA A, Sifrim D, Fujiwara Y
    Esophageal Reflux Hypersensitivity: A Comprehensive Review.
    Gut Liver. 2023 Jan 2. doi: 10.5009/gnl220373.
    PubMed    
    Abstract available
    
    

36. ABDELMALAK MFL, Abdelrahim DS, George Michael TMA, Abdel-Maksoud OM, et al
    Vitamin D and lactoferrin attenuate stress-induced colitis in Wistar rats via enhancing AMPK expression with inhibiting mTOR-STAT3 signaling and modulating autophagy.
    Cell Biochem Funct. 2023 Jan 1. doi: 10.1002/cbf.3774.
    PubMed    
    Abstract available
    
    

37. DINNING PG
    Colonic Response to Physiological, Chemical, Electrical and Mechanical Stimuli; What Can Be Used to Define Normal Motility?
    Adv Exp Med Biol. 2022;1383:125-132.
    PubMed    
    Abstract available
    
    

38. ANNAHAZI A, Schemann M
    Contribution of the Enteric Nervous System to Autoimmune Diseases and Irritable Bowel Syndrome.
    Adv Exp Med Biol. 2022;1383:1-8.
    PubMed    
    Abstract available
    
    

39. ISMAIL MH, Abbas SK, Molan AL
    Novel association between blastocystosis and some hemogram parameters in Iraqi people with and without irritable bowel syndrome.
    Ann Parasitol. 2022;68:491-500.
    PubMed    
    Abstract available
    
    

40. GREEN JE, Berk M, Mohebbi M, Loughman A, et al
    Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial.
    Can J Psychiatry. 2023 Jan 13:7067437221150508. doi: 10.1177/07067437221150508.
    PubMed    
    Abstract available
    
    

41. CHEN Q, Zhang H, Sun CY, He QY, et al
    Evaluation of two laboratory model methods for diarrheal irritable bowel syndrome.
    Mol Med. 2023;29:5.
    PubMed    
    Abstract available
    
    

42. BREEN-LYLES M, Decuir M, Byale A, Smith K, et al
    Impact of Rome IV criteria on the prevalence of post-infection irritable bowel syndrome.
    Neurogastroenterol Motil. 2023 Jan 12:e14532. doi: 10.1111/nmo.14532.
    PubMed    
    Abstract available
    
    

43. ATMANI K, Wuestenberghs F, Baron M, Boulete I, et al
    Bladder-colon chronic cross-sensitization involves neuro-glial pathways in male mice.
    World J Gastroenterol. 2022;28:6935-6949.
    PubMed    
    Abstract available
    
    

44. CELLERI M, Koutsovitis F, Donatti S, Ierache J, et al
    [Digestivamente: Mobile application for patients with irritable bowel syndrome].
    Vertex. 2022;33.
    PubMed    
    Abstract available
    
    

45. DIPASQUALE V, Palermo L, Barbalace A, Tumminello G, et al
    Randomised controlled trial of melatonin for paediatric functional abdominal pain disorders.
    J Paediatr Child Health. 2023 Jan 9. doi: 10.1111/jpc.16323.
    PubMed    
    Abstract available
    
    

46. YAN W, Kan Z, Li Z, Ma Y, et al
    Identification of Potential MicroRNA-MRNA Regulatory Relationship Pairs in Irritable Bowel Syndrome with Diarrhea.
    Comb Chem High Throughput Screen. 2023.
    PubMed    
    Abstract available
    
    

47. MATTHEWS SW, Plantinga A, Burr R, Cain KC, et al
    Exploring the Role of Vitamin D and the Gut Microbiome: A Cross-Sectional Study of Individuals with Irritable Bowel Syndrome and Healthy Controls.
    Biol Res Nurs. 2023 Jan 9:10998004221150395. doi: 10.1177/10998004221150395.
    PubMed    
    Abstract available
    
    

48. JACOBS JP, Lagishetty V, Hauer MC, Labus JS, et al
    Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes.
    Microbiome. 2023;11:5.
    PubMed    
    Abstract available
    
    

49. WANG X, Shi X, Lv J, Zhang J, et al
    Acupuncture and related therapies for the anxiety and depression in irritable bowel syndrome with diarrhea (IBS-D): A network meta-analysis of randomized controlled trials.
    Front Psychiatry. 2022;13:1067329.
    PubMed    
    Abstract available
    
    

50. ISLAM Z, D'Silva A, Raman M, Nasser Y, et al
    The role of mind body interventions in the treatment of irritable bowel syndrome and fibromyalgia.
    Front Psychiatry. 2022;13:1076763.
    PubMed    
    Abstract available
    
    

51. MORTAZAVI M, Adibi P, Hassanzadeh Keshteli A, Feizi A, et al
    Comparison of Gastrointestinal Symptoms between Patients Undergoing Hemodialysis and Healthy Population.
    Middle East J Dig Dis. 2022;14:310-316.
    PubMed    
    Abstract available
    
    

52. SHARIFI M, Safarpour AR, Barati-Boldaji R, Rahmati L, et al
    Post-Infectious Irritable Bowel Syndrome after an Epidemic of Gastroenteritis in South of Iran.
    Middle East J Dig Dis. 2022;14:304-309.
    PubMed    
    Abstract available
    
    

53. HASSNINE A, Saad Z
    Rome IV Diagnostic Criteria for Functional Gastrointestinal Disorders in Patients with Chronic Hepatitis C Virus.
    Middle East J Dig Dis. 2022;14:214-221.
    PubMed    
    Abstract available
    
    

54. ALAVINEJAD P, Mousavi Ghanavati P, Alboraie M, Emara M, et al
    Irritable Bowel Syndrome Demographics: A Middle Eastern Multinational Cross-sectional Study.
    Middle East J Dig Dis. 2022;14:222-228.
    PubMed    
    Abstract available
    
    

55. FRIES J, Baudson TG, Kovacs K, Pietschnig J, et al
    Bright, but allergic and neurotic? A critical investigation of the "overexcitable genius" hypothesis.
    Front Psychol. 2022;13:1051910.
    PubMed    
    Abstract available
    
    

56. SROKA N, Rydzewska-Rosolowska A, Kakareko K, Rosolowski M, et al
    Show Me What You Have Inside-The Complex Interplay between SIBO and Multiple Medical Conditions-A Systematic Review.
    Nutrients. 2022;15:90.
    PubMed    
    Abstract available
    
    

57. DE GRAAF MCG, Scheijen JLJM, Spooren CEGM, Mujagic Z, et al
    The Intake of Dicarbonyls and Advanced Glycation Endproducts as Part of the Habitual Diet Is Not Associated with Intestinal Inflammation in Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients.
    Nutrients. 2022;15:83.
    PubMed    
    Abstract available
    
    

58. RODRIGUEZ-SOJO MJ, Garcia-Garcia J, Ruiz-Malagon AJ, Diez-Echave P, et al
    Beneficial Effects of Limosilactobacillus fermentum in the DCA Experimental Model of Irritable Bowel Syndrome in Rats.
    Nutrients. 2022;15:24.
    PubMed    
    Abstract available
    
    

59. KOSSEWSKA J, Bierlit K, Trajkovski V
    Personality, Anxiety, and Stress in Patients with Small Intestine Bacterial Overgrowth Syndrome. The Polish Preliminary Study.
    Int J Environ Res Public Health. 2022;20:93.
    PubMed    
    Abstract available
    
    

60. IQBAL Z, Liu S, Lei Z, Ramkrishnan AS, et al
    Astrocyte L-Lactate Signaling in the ACC Regulates Visceral Pain Aversive Memory in Rats.
    Cells. 2022;12:26.
    PubMed    
    Abstract available
    
    

61. MIDYA US, Bandyopadhyay S
    Elucidating the Sluggish Water Dynamics at the Ice-Binding Surface of the Hyperactive Tenebrio molitor Antifreeze Protein.
    J Phys Chem B. 2023;127:121-132.
    PubMed    
    Abstract available
    
    

62. FENG K, Zhang H, Jiang Z, Zhou M, et al
    SFTS bunyavirus NSs protein sequestrates mTOR into inclusion bodies and deregulates mTOR-ULK1 signaling, provoking pro-viral autophagy.
    J Med Virol. 2023;95:e28371.
    PubMed    
    Abstract available
    
    

63. PETERS SL, Gibson PR, Halmos EP
    Smartphone app-delivered gut-directed hypnotherapy improves symptoms of self-reported irritable bowel syndrome: A retrospective evaluation.
    Neurogastroenterol Motil. 2023 Jan 20:e14533. doi: 10.1111/nmo.14533.
    PubMed    
    Abstract available
    
    

64. BURTON MURRAY H, Weeks I, Thurler A, Calabrese S, et al
    Nurse practitioner-delivered cognitive-behavioral treatment as a novel implementation route for irritable bowel syndrome: A proof of concept.
    Neurogastroenterol Motil. 2023 Jan 20:e14526. doi: 10.1111/nmo.14526.
    PubMed    
    Abstract available
    
    

65. JAVED M, Yadav T, Shakil J, Haider Zaidi ST, et al
    Prevalence of irritable bowel syndrome and functional dyspepsia and their relationship with generalized anxiety disorder among medical students in Karachi.
    J Pak Med Assoc. 2022;72:2132-2136.
    PubMed    
    Abstract available
    
    

66. ABUELAZM M, Abdelazeem B
    The efficacy of vitamin D supplementation for irritable bowel syndrome: narrow scope and GRADE miss-interpretation.
    Nutr J. 2023;22:8.
    PubMed    
    Abstract available
    
    

67. ZHANG S, Hong G, Li G, Qian W, et al
    Modulation of the microbiota across different intestinal segments by Rifaximin in PI-IBS mice.
    BMC Microbiol. 2023;23:22.
    PubMed    
    Abstract available
    
    

68. DE PALMA G, Reed DE, Bercik P
    Diet-microbial cross-talk underlying increased visceral perception.
    Gut Microbes. 2023;15:2166780.
    PubMed    
    Abstract available
    
    

69. CHAUHAN A, Das P, Singh A, Mehra L, et al
    Gastrointestinal tract involvement in patients with potential celiac disease beyond the small intestine: An early proof with IgA anti-tissue transglutaminase-2 antibody deposits.
    Indian J Pathol Microbiol. 2023;66:24-30.
    PubMed    
    Abstract available
    
    

70. HAO S, Yang S, Zhang N, Cheng H, et al
    Fecal Microbiota Transplantation Research over the Past Decade: Current Status and Trends.
    Can J Infect Dis Med Microbiol. 2023;2023:6981721.
    PubMed    
    Abstract available
    
    

71. KIM GH, Lee K, Shim JO
    Gut Bacterial Dysbiosis in Irritable Bowel Syndrome: a Case-Control Study and a Cross-Cohort Analysis Using Publicly Available Data Sets.
    Microbiol Spectr. 2023 Jan 19:e0212522. doi: 10.1128/spectrum.02125.
    PubMed    
    Abstract available
    
    

72. KOLLER D, Pathak GA, Wendt FR, Tylee DS, et al
    Epidemiologic and Genetic Associations of Endometriosis With Depression, Anxiety, and Eating Disorders.
    JAMA Netw Open. 2023;6:e2251214.
    PubMed    
    Abstract available
    
    

73. MADVA EN, Harnedy LE, Longley RM, Rojas Amaris A, et al
    Positive psychological well-being: A novel concept for improving symptoms, quality of life, and health behaviors in irritable bowel syndrome.
    Neurogastroenterol Motil. 2023 Jan 17:e14531. doi: 10.1111/nmo.14531.
    PubMed    
    Abstract available
    
    

74. HORN A, Stangl S, Parisi S, Bauer N, et al
    Systematic review with meta-analysis: Stress-management interventions for patients with irritable bowel syndrome.
    Stress Health. 2023 Jan 17. doi: 10.1002/smi.3226.
    PubMed    
    Abstract available
    
    

75. QI LY, Wang Y, Wang LQ, She YF, et al
    Correction: Acupuncture for the treatment of diarrheal-predominant irritable bowel syndrome: study protocol for a pilot randomized controlled trial.
    Trials. 2023;24:28.
    PubMed    
    
    
    

76. NASERI K, Dabiri H, Olfatifar M, Shahrbaf MA, et al
    Evaluation of gut microbiota of iranian patients with celiac disease, non-celiac wheat sensitivity, and irritable bowel syndrome: are there any similarities?
    BMC Gastroenterol. 2023;23:15.
    PubMed    
    Abstract available
    
    

77. PHILIPSON A, Duberg A, Hagberg L, Hogstrom S, et al
    The Cost-Effectiveness of a Dance and Yoga Intervention for Girls with Functional Abdominal Pain Disorders.
    Pharmacoecon Open. 2023 Jan 16. doi: 10.1007/s41669-022-00384.
    PubMed    
    Abstract available
    
    

78. CHOJNACKI C, Blonska A, Medrek-Socha M, Chojnacki M, et al
    The clinical value of breath ammonia determination in patients with irritable bowel syndrome.
    Pol Merkur Lekarski. 2022;50:360-363.
    PubMed    
    Abstract available
    
    

79. ARUTYUNOV GP, Tarlovskaya EI, Arutyunov AG, Belenkov YN, et al
    [capital A, Cyrillicsmall en, Cyrillicsmall a, Cyrillicsmall el, Cyrillicsmall i, Cyrillicsmall ze, Cyrillic small ve, Cyrillicsmall el, Cyrillicsmall i, Cyrillicsmall ya, Cyrillicsmall en, Cyrillicsmall i, Cyrillicsmall ya, Cyrillic small ka, Cyrillicsm
    Kardiologiia. 2022;62:38-49.
    PubMed    
    Abstract available
    
    

80. LO PRESTI A, Del Chierico F, Altomare A, Zorzi F, et al
    Phylogenetic analysis of Prevotella copri from fecal and mucosal microbiota of IBS and IBD patients.
    Therap Adv Gastroenterol. 2023;16:17562848221136328.
    PubMed    
    Abstract available
    
    

81. QIAN W, Li W, Chen X, Cui L, et al
    Exploring the mechanism of Xingpi Capsule in diarrhea predominant-irritable bowel syndrome treatment based on multiomics technology.
    Phytomedicine. 2023;111:154653.
    PubMed    
    Abstract available
    
    

82. ARUTYUNOV GP, Tarlovskaya EI, Arutyunov AG, Belenkov YN, et al
    [Not Available].
    Kardiologiia. 2022;62:38-49.
    PubMed    
    Abstract available
    
    

83. CASTRO E COSTA AR, Mysore S, Paruchuri P, Chen KY, et al
    PolyQ-Expanded Mutant Huntingtin Forms Inclusion Body Following Transient Cold Shock in a Two-Step Aggregation Mechanism.
    ACS Chem Neurosci. 2023;14:277-288.
    PubMed    
    Abstract available
    
    

84. YU L, Huang C, Yang W, Ren Z, et al
    Aqueous cinnamon extract ameliorates bowel dysfunction and enteric 5-HT synthesis in IBS rats.
    Front Pharmacol. 2023;13:1010484.
    PubMed    
    Abstract available
    
    

85. OLIVEIRA CR, Jason LA, Unutmaz D, Bateman L, et al
    Improvement of Long COVID symptoms over one year.
    Front Med (Lausanne). 2023;9:1065620.
    PubMed    
    Abstract available
    
    

86. MCHARG AS, Leach S
    The role of the gut microbiome in paediatric irritable bowel syndrome.
    AIMS Microbiol. 2022;8:454-469.
    PubMed    
    Abstract available
    
    

87. GROSSI E
    Do artificial neural networks love sex? How the combination of artificial neural networks with evolutionary algorithms may help to identify gender influence in rheumatic diseases.
    Clin Exp Rheumatol. 2023;41:1-5.
    PubMed    
    Abstract available
    
    

88. ZHANG X, Liu Y, Ou Y, Yang M, et al
    Gender-specific association between the regular use of statins and the risk of irritable bowel syndrome: A population-based prospective cohort study.
    Front Pharmacol. 2023;13:1044542.
    PubMed    
    Abstract available
    
    

89. BURNS GL, Bruce JK, Minahan K, Mathe A, et al
    Type 2 and type 17 effector cells are increased in the duodenal mucosa but not peripheral blood of patients with functional dyspepsia.
    Front Immunol. 2023;13:1051632.
    PubMed    
    Abstract available
    
    

90. CSASZAR-NAGY N, Bokkon I
    Hypnotherapy and IBS: Implicit, long-term stress memory in the ENS?
    Heliyon. 2022;9:e12751.
    PubMed    
    Abstract available
    
    

91. GUAN L, Liu Y, Wu B, Chen A, et al
    Research hotspots and trends in visceral pain research: A global comprehensive bibliometric analysis.
    Front Mol Neurosci. 2023;15:1022463.
    PubMed    
    Abstract available
    
    

92. MADVA EN, Sadlonova M, Harnedy LE, Longley RM, et al
    Positive psychological well-being and clinical characteristics in IBS: A systematic review.
    Gen Hosp Psychiatry. 2023;81:1-14.
    PubMed    
    Abstract available
    
    

93. SUN Y, Li H, Liu L, Bai X, et al
    A Novel Mast Cell Stabilizer JM25-1 Rehabilitates Impaired Gut Barrier by Targeting the Corticotropin-Releasing Hormone Receptors.
    Pharmaceuticals (Basel). 2022;16:47.
    PubMed    
    Abstract available
    
    

94. MATERA R, Lucchi E, Valgimigli L
    Plant Essential Oils as Healthy Functional Ingredients of Nutraceuticals and Diet Supplements: A Review.
    Molecules. 2023;28:901.
    PubMed    
    Abstract available
    
    

95. ALEMAN RS, Moncada M, Aryana KJ
    Leaky Gut and the Ingredients That Help Treat It: A Review.
    Molecules. 2023;28:619.
    PubMed    
    Abstract available
    
    

96. ALI MK, Chen JDZ
    Roles of Heart Rate Variability in Assessing Autonomic Nervous System in Functional Gastrointestinal Disorders: A Systematic Review.
    Diagnostics (Basel). 2023;13:293.
    PubMed    
    Abstract available
    
    

97. NICOLA S, Cinetto F, Della Mura S, Lo Sardo L, et al
    The Importance of Endoscopy with Biopsy: Real-World Evidence of Gastrointestinal Involvement in Primary Immunodeficiency in Two Main Northern Italian Centres.
    Biomedicines. 2023;11:170.
    PubMed    
    Abstract available
    
    

98. AWAD K, Barmeyer C, Bojarski C, Nagel O, et al
    Impaired Intestinal Permeability of Tricellular Tight Junctions in Patients with Irritable Bowel Syndrome with Mixed Bowel Habits (IBS-M).
    Cells. 2023;12:236.
    PubMed    
    Abstract available
    
    

99. LI Y, Li YR, Jin Y, Li MY, et al
    Involvement of enteric glial cells in colonic motility in a rat model of irritable bowel syndrome with predominant diarrhea.
    J Chem Neuroanat. 2023;128:102235.
    PubMed    
    Abstract available
    
    

100. ROCA-PINILLA R, Aris A, Garcia-Fruitos E
     Antimicrobial Applications of Inclusion Bodies.
     Methods Mol Biol. 2023;2617:257-269.
     PubMed    
     Abstract available
     
     

101. RANI AK, Naira VR, Rathore AS
     Method for Inclusion Bodies Production via E. coli Host System: rGCSF as Model Biotherapeutic Protein.
     Methods Mol Biol. 2023;2617:249-256.
     PubMed    
     Abstract available
     
     

102. SHARMA R, Anupa A, Rathore AS
     Refolding of Proteins Expressed as Inclusion Bodies in E. coli.
     Methods Mol Biol. 2023;2617:201-208.
     PubMed    
     Abstract available
     
     

103. EBNER J, Humer D, Sedlmayr V
     Unit Operation-Spanning Investigation of the Redox System.
     Methods Mol Biol. 2023;2617:165-176.
     PubMed    
     Abstract available
     
     

104. ROUFARSHBAF M, Akbari V
     Development of Solubilization and Refolding Buffers.
     Methods Mol Biol. 2023;2617:155-164.
     PubMed    
     Abstract available
     
     

105. KAMEL S, Schollmeyer J, Kurreck A, Neubauer P, et al
     Optimization of Inclusion Body Formation and Purification in Multi-well Plates.
     Methods Mol Biol. 2023;2617:121-138.
     PubMed    
     Abstract available
     
     

106. VALDEZ-CRUZ NA, Trujillo-Roldan MA
     Thermoinducible E. coli for Recombinant Protein Production in Inclusion Bodies.
     Methods Mol Biol. 2023;2617:17-30.
     PubMed    
     Abstract available
     
     

107. KOPP J, Spadiut O
     Inclusion Bodies: Status Quo and Perspectives.
     Methods Mol Biol. 2023;2617:1-13.
     PubMed    
     Abstract available
     
     

108. MAALOUF E, Grover M
     Editorial: repurposed linaclotide and the quest for abdominal pain management in irritable bowel syndrome.
     Aliment Pharmacol Ther. 2023;57:261-262.
     PubMed    
     
     
     

109. MANTEGAZZA G, Gargari G, Guglielmetti S
     Editorial: bacterial gut symbionts as live biotherapeutic agents in irritable bowel syndrome-a rosy future despite potential long-term safety concerns.
     Aliment Pharmacol Ther. 2023;57:345-346.
     PubMed    
     
     
     

110. QUIGLEY EMM, Stevenson A, Jeffery I, Masters J, et al
     Editorial: bacterial gut symbionts as live biotherapeutic agents in IBS-a rosy future despite potential long-term safety concerns. Authors' reply.
     Aliment Pharmacol Ther. 2023;57:347-348.
     PubMed    
     
     
     

111. DAMIANOS JA, Tomar SK, Azpiroz F, Barba E, et al
     Abdominophrenic Dyssynergia: A Narrative Review.
     Am J Gastroenterol. 2023;118:41-45.
     PubMed    
     Abstract available
     
     

112. BUSTOS FERNANDEZ LM, Man F, Lasa JS
     "Impact of Saccharomyces boulardii CNCM I-745 on bacterial overgrowth and composition of intestinal microbiota in IBS-D patients: results of a randomized pilot study".
     Dig Dis. 2023 Jan 11. doi: 10.1159/000528954.
     PubMed    
     Abstract available
     
     

113. PATRICK KS, Sanborn V, Gunstad J, Spitznagel MB, et al
     Poorer Cognitive Performance Is Associated with Gastrointestinal Symptoms in Otherwise Healthy Young Adults.
     Dig Dis. 2023;41:74-79.
     PubMed    
     Abstract available
     
     

114. YU V, McHenry N, Proctor S, Wolf J, et al
     Gastroenterologist Primer: Endometriosis for Gastroenterologists.
     Dig Dis Sci. 2023 Jan 18. doi: 10.1007/s10620-022-07674.
     PubMed    
     Abstract available
     
     

115. ZHOU Q, Yang L, Verne ML, Zhang BB, et al
     Catechol-O-Methyltransferase Loss Drives Cell-Specific Nociceptive Signaling via the Enteric COMT/miR-155/TNF-alpha Axis.
     Gastroenterology. 2023 Jan 6:S0016-5085(23)00008.
     PubMed    
     Abstract available
     
     

116. TUCK CJ, Abu Omar A, De Palma G, Osman S, et al
     Changes in signalling from faecal neuroactive metabolites following dietary modulation of IBS pain.
     Gut. 2022 Dec 13:gutjnl-2022-327260. doi: 10.1136/gutjnl-2022-327260.
     PubMed    
     Abstract available
     
     

117. MARASCO G, Cremon C, Barbaro MR, Cacciari G, et al
     Post COVID-19 irritable bowel syndrome.
     Gut. 2022 Dec 9:gutjnl-2022-328483. doi: 10.1136/gutjnl-2022-328483.
     PubMed    
     Abstract available
     
     

118. HOUDEVILLE C, Chartier S, Delaye M, Fabiani B, et al
     White small bowel in a patient with chronic diarrhoea.
     Gut. 2023;72:225-324.
     PubMed    
     
     
     

119. VANUYTSEL T, Bercik P, Boeckxstaens G
     Understanding neuroimmune interactions in disorders of gut-brain interaction: from functional to immune-mediated disorders.
     Gut. 2023 Jan 19:gutjnl-2020-320633. doi: 10.1136/gutjnl-2020-320633.
     PubMed    
     Abstract available
     
     

120. BOUSABA J, Zheng T, Dilmaghani S, Johnson S, et al
     Effect of rapid colonic transit on stool microbiome and short-chain fatty acids in diarrhoea-predominant irritable bowel syndrome.
     Gut. 2023 Jan 19:gutjnl-2022-329359. doi: 10.1136/gutjnl-2022-329359.
     PubMed    
     
     
     

121. ZHU Z, Chen X, Wang C, Zhang S, et al
     Haemorrhoidal disease reduces the risk of diverticular disease and irritable bowel syndrome: a Mendelian randomisation study.
     Gut. 2023 Jan 24:gutjnl-2022-329307. doi: 10.1136/gutjnl-2022-329307.
     PubMed    
     
     
     

122. SIKANDER A, Rana SV, Sinha SK, Prasad KK, et al
     Association of serotonin transporter promoter polymorphism (5-HTTLPR) with orocecal transit time in irritable bowel syndrome.
     Indian J Gastroenterol. 2022 Dec 27. doi: 10.1007/s12664-022-01280.
     PubMed    
     Abstract available
     
     

123. GHOSHAL U, Biswas SN, Dixit VK, Yadav JS, et al
     Anxiety and depression in Indian patients with irritable bowel syndrome: A meta-analysis.
     Indian J Gastroenterol. 2023 Jan 19. doi: 10.1007/s12664-022-01300.
     PubMed    
     Abstract available
     
     

124. TARAR ZI, Farooq U, Zafar Y, Gandhi M, et al
     Burden of anxiety and depression among hospitalized patients with irritable bowel syndrome: a nationwide analysis.
     Ir J Med Sci. 2023 Jan 3. doi: 10.1007/s11845-022-03258.
     PubMed    
     Abstract available
     
     

125. KOSEKI T, Muratsubaki T, Tsushima H, Morinaga Y, et al
     Impact of mindfulness tendency and physical activity on brain-gut interactions.
     J Gastroenterol. 2023 Jan 11. doi: 10.1007/s00535-022-01938.
     PubMed    
     Abstract available
     
     

126. WINNICK JB, Chancey L, Buzenski J, Sukumar K, et al
     Telehealth for Pediatric Disorders of Gut-Brain Interaction during the COVID-19 Pandemic.
     J Pediatr Gastroenterol Nutr. 2022 Dec 27. doi: 10.1097/MPG.0000000000003687.
     PubMed    
     Abstract available
     
     

127. VLIEGER AM, Assa A, Borrelli O, Broekaert I, et al
     Hypnotherapy in Pediatric Gastroenterology.
     J Pediatr Gastroenterol Nutr. 2023;76:9-13.
     PubMed    
     Abstract available
     
     

128. TUBIANA T, Sillitoe I, Orengo C, Reuter N, et al
     Dissecting peripheral protein-membrane interfaces.
     PLoS Comput Biol. 2022;18:e1010346.
     PubMed    
     Abstract available
     
     

129. KHEMNU N, Serichantalergs O, Ruekit S, Lertsethtakarn P, et al
     Description of novel capsule biosynthesis loci of Campylobacter jejuni clinical isolates from South and South-East Asia.
     PLoS One. 2023;18:e0280583.
     PubMed    
     Abstract available